• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Neuralstem, Inc. (CUR)

    -NYSE MKT
    3.20 Down 0.07(2.14%) 4:00PM EST
    Add to Portfolio
    Prev Close:3.27
    Open:3.31
    Bid:3.12 x 1000
    Ask:3.20 x 100
    1y Target Est:7.00
    Beta:2.35
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:3.13 - 3.34
    52wk Range:2.12 - 4.81
    Volume:624,163
    Avg Vol (3m):705,327
    Market Cap:279.55M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CURDown 2.14%279.55M
    GERNDown 2.67%515.65M
    STEM 0.00%73.54M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17,140.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback